Hint mode is switched on Switch off
Cbonds API
Integrate prices, fundamentals and corporate actions into your workflow

Get Global Stock Data via API

  • Prices & history
  • Fundamentals
  • Dividends & corporate actions

Sangamo Therapeutics, ordinary share
SGMO, US8006771062

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access
Add a stock to WL
Choose all Reset all
Save Close
Sangamo Therapeutics, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Latest quotes

Try in 7-days Trial access

  • Get full online access to the database
  • Use our powerful bond screener
  • Track bond prices from 400+ sources
  • Smart Portfolio Monitoring
Unlock Data
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Issuer

Profile
Sangamo Therapeutics, Inc. focuses on translating ground-breaking science into genomic therapies that transform patients' lives using platform technologies in genome editing, gene therapy, gene regulation, and cell therapy.
  • Issuer
  • Full borrower / issuer name
    Sangamo Therapeutics, Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    SGMO
  • Placement
    06.04.2000
  • Lock up period
    180
  • Number of papers
    3,500,000
  • Volume of raised funds
    52.5 mln USD
  • Raised funds in USD
    -
  • Placement share
    16%
  • Final placement price
    15 USD
  • Price change since placement date
    -99.51%
  • By capitalization
    312.81 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    SGMO
  • Placement
    13.05.2025
  • Lock up period
    180
  • Number of papers
    12,235,000
  • Volume of raised funds
    6.12 mln USD
  • Raised funds in USD
    -
  • Placement share
    5.15%
  • Final placement price
    0.5 USD
  • Price change since placement date
    -85.2%
  • By capitalization
    118.8 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    SGMO
  • Placement
    24.04.2018
  • Lock up period
    180
  • Number of papers
    11,019,284
  • Volume of raised funds
    200 mln USD
  • Raised funds in USD
    -
  • Final placement price
    18.15 USD
  • Price change since placement date
    -99.59%
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    SGMO
  • Placement
    22.06.2017
  • Lock up period
    180
  • Number of papers
    10,000,000
  • Volume of raised funds
    72.5 mln USD
  • Raised funds in USD
    -
  • Placement share
    12.23%
  • Final placement price
    7.25 USD
  • Price change since placement date
    -98.98%
  • By capitalization
    592.7 mln USD
Other placements of the issuer Hide

Indicators

IFRS/US GAAP reports

  • 2026

  • 2025

  • 2024

  • 2023

  • 2022

  • 2021

  • 2020

  • 2019

  • 2018

  • 2017

  • 2016

  • 2015

  • 2014

    • Show all Hide

    News

    All organization news

    Holders

    Industry Leaders

    Registration is required to get access.